Literature DB >> 8122614

Incidence, predictors, and management of acute coronary occlusion after coronary angioplasty.

P J de Feyter1, P P de Jaegere, P W Serruys.   

Abstract

Acute coronary occlusion occurs in 4.3% to 8.3% of patients during coronary angioplasty. Its occurrence is difficult to predict in an individual patient. At high risk are patients with unstable angina, intracoronary thrombus, extreme age, long complex lesions, and diffuse disease. "Standard" management including redilation (prolonged perfusion) thrombolytic treatment and emergency bypass surgery is only successful in approximately 50% of the patients and is associated with a high mortality and myocardial infarction rate of < 6% and 30%, respectively. Bail-out stent implantation appears to emerge as an effective alternative in suitable patients and might reduce mortality, the apparent progression to myocardial infarction, or might decrease the need for emergency bypass. New techniques including directional atherectomy, rotational ablation, or the excimer laser are associated with a similar frequency of acute occlusion. Immediate access to a surgical back-up facility remains necessary to treat refractory acute occlusions.

Entities:  

Mesh:

Year:  1994        PMID: 8122614     DOI: 10.1016/0002-8703(94)90675-0

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

Review 1.  Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.

Authors:  Shann S Yu; Ryan A Ortega; Brendan W Reagan; John A McPherson; Hak-Joon Sung; Todd D Giorgio
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-08-10

2.  Coating of cardiovascular stents with a semiconductor to improve their hemocompatibility.

Authors:  A Bolz; M Amon; C Ozbek; B Heublein; M Schaldach
Journal:  Tex Heart Inst J       Date:  1996

3.  Catheter based intracoronary brachytherapy leads to increased platelet activation.

Authors:  M Jaster; V Fuster; P Rosenthal; M Pauschinger; Q-V Tran; D Janssen; W Hinkelbein; P Schwimmbeck; H-P Schultheiss; U Rauch
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

Review 4.  Biodegradable Metals for Cardiovascular Stents: from Clinical Concerns to Recent Zn-Alloys.

Authors:  Patrick K Bowen; Emily R Shearier; Shan Zhao; Roger J Guillory; Feng Zhao; Jeremy Goldman; Jaroslaw W Drelich
Journal:  Adv Healthc Mater       Date:  2016-04-20       Impact factor: 9.933

5.  Comparison of zotarolimus- and everolimus-eluting coronary stents: final 5-year report of the RESOLUTE all-comers trial.

Authors:  Javaid Iqbal; Patrick W Serruys; Sigmund Silber; Henning Kelbaek; Gert Richardt; Marie-Angele Morel; Manuela Negoita; Pawel E Buszman; Stephan Windecker
Journal:  Circ Cardiovasc Interv       Date:  2015-06       Impact factor: 6.546

6.  Drug-eluting coronary stents - focus on improved patient outcomes.

Authors:  Zehra Jaffery; Amit Prasad; John H Lee; Christopher J White
Journal:  Patient Relat Outcome Meas       Date:  2011-09-22

7.  Stent fracture: how frequently is it recognized?

Authors:  Mohammed Khalil Mohsen; Awad Alqahtani; Jassim Al Suwaidi
Journal:  Heart Views       Date:  2013-04

8.  Early ambulatory discharge is safe and feasible after transradial coronary interventions.

Authors:  Alper Aydin; Tayfun Gurol; Ozer Soylu; Bahadir Dagdeviren
Journal:  Int J Cardiol Heart Vessel       Date:  2014-03-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.